DestiNA Genomics Company
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
Technology:
Anti-infective Drugs
Industry:
Gene therapy
Headquarters:
Edinburgh, Edinburgh, City of, United Kingdom
Founded Date:
2010
Employees Number:
11-50
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Register and Claim Ownership